CRA provided testimony in support of Masimo in its successful effort to refute monopolization, tying, and other antitrust counterclaims following a competitor’s infringement of its medical device patents. The team was led by Tim Snail and included Sharon Pang, Eyal Dvir, Omeed Alerasool, Ryne Belliston, Carl Hayden, Daniel Ladd, Joseph Marin, Flore Nouvel, and Sarah Black.
CRA Competition's response to EU Draft Merger Guidelines: An economic perspective on the emerging framework
Our European Competition team has contributed to the economic assessment in nearly a third of distinct merger decisions cited in the draft, (46 out of 164)...